Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatic Disease Report Card 2022 Released: No A’s Given Overall; Oklahoma Ranks Most Improved

Vanessa Caceres  |  Issue: October 2022  |  September 13, 2022

In honor of Rheumatic Disease Awareness Month, the ACR released a new Rheumatic Disease Report Card as part of its Simple Tasks public awareness campaign. The report card seeks to help answer the question, “How easy is it to live with rheumatic disease in my state?”

First released in 2018, the report card has been updated to provide new scores to see how much states have improved. It considers such factors as access to care, affordability, and activity and lifestyle elements when providing each state with a score and corresponding letter grade.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

2022 RDAM Report CardThe access category considers number of residents per rheumatologist, the percentage of residents who lack insurance coverage, the strength of the state’s laws to limit prior authorization and the strength of the state’s legislation to limit insurers’ use of step therapy.

The affordability category awards states points on the basis of the presence of state legislation limiting insurer use of specialty tiers, the strength of the state’s laws promoting pharmacy benefit manager (PBM) transparency and the presence of state legislation preventing insurers from implementing copay accumulators.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The activity category looks at such factors as the prevalence of arthritis-attributable activity limitation among adults, the percentage of adults who are physically inactive and the prevalence of Centers for Disease Control and Prevention (CDC) funded arthritis intervention programs.

Each state received a numerical score and a letter grade in each area. The potential total score was 150 points. States then received an overall letter grade to reflect their score.

Which States Made the Grade?

No states received an overall grade of A. However, five states achieved a B, the highest grades awarded:

  • New York (a score of 111 out of 150);
  • Virginia (106/150);
  • Maryland (105/150);
  • California (93/150); and
  • Illinois (92/150).

Most states received an overall grade of C or D (see map, above).

The state with the highest score in the 2018 report card was Maryland, followed by New York, Vermont, Colorado and Connecticut.

This year’s report card recognizes Oklahoma as the most improved state … . Its score went up by 31 points, & it moved from the lowest scoring state [in 2018] to a ranking of 20th place in 2022.

This year’s top scorer, New York, earned an A for access and was the only state to do so in that category. “The A in the access category was due to the strength of its state legislation to limit insurer use of prior authorization and step therapy, as well as its low ratio of people per rheumatologist,” says Jocelyn Givens, director of public relations and communications at the ACR. New York received a B for affordability and activity.

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of RheumatologyFrom the College Tagged with:RDAMReport CardRheumatic Disease Awareness Month

Related Articles

    Maryland Gets an A; Most States Receive a C on ACR’s 1st Rheumatic Disease Report Card

    September 5, 2018

    In a first-of-its-kind report card, the ACR shows that many changes are needed for states to improve patient access to affordable and effective rheumatology care…

    Credit Card Program Helps Physician Practice Manage Its Income

    March 20, 2017

    As Erin L. Arnold, MD, partner, Orthopaedics and Rheumatology of the North Shore, in Skokie, Ill, observed patients’ health insurance deductibles and copays getting dramatically higher and higher, she decided that it was time to explore a program that would require patients to keep a credit card on file. “As a private practice and small…

    Yellow Card for the Yellow Card

    May 13, 2021

    Independence Day. I can’t wait. Generally, it’s not a holiday that carries a lot of meaning for me. Having grown up in New York and Boston, the smaller firework displays that take place in Baltimore fail to impress. Also, as a program director, the holiday falls in the middle of the new fellows’ first week…

    Help Your Patients Live Well with Rheumatic Disease

    September 20, 2018

    As rheumatology professionals, we focus on how to achieve better outcomes for our patients: lower disease activity, remission, milder symptoms and prevention of joint damage or serious complications, such as heart disease. Another outcome is just as important: good quality of life. What can we do to engage our current patients and those at risk…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences